South African scientists are suggesting that the antibodies triggered by exposure to the country’s coronavirus variant might likely prevent infection by other variants of the virus. If the study is successfully peer-reviewed, it offers hope that COVID-19 vaccines based on the South African variant (501Y.V2) could protect against the multiple mutations circulating in different parts…